An integration of deep viral suppression with sequential immune modulation (cocktail therapy) to restore antiviral capacity: the future of chronic hepatitis B?

J Hepatol. 2015 Jan;62(1):240-1. doi: 10.1016/j.jhep.2014.10.002. Epub 2014 Oct 13.

Authors

Di Wu¹, Meifang Han¹, Qin Ning²

Affiliations

¹ Department and Institute of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Department and Institute of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: qning@vip.sina.com.

PMID: 25308175
DOI: 10.1016/j.jhep.2014.10.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Female
Guanine / analogs & derivatives*
Hepatitis B Surface Antigens / blood*
Hepatitis B e Antigens / blood*
Hepatitis B virus*
Hepatitis B, Chronic*
Humans
Interferon-alpha / administration & dosage*
Male
Polyethylene Glycols / administration & dosage*

Substances

Hepatitis B Surface Antigens
Hepatitis B e Antigens
Interferon-alpha
Polyethylene Glycols
Guanine